This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
“Is Your Voice Biometric Data? BIPA, AI and the New Era of Voiceprint Litigation” looks ...
During this course you will take a deep dive into federal bid protest litigation at the U.S. Court o...
Turn decades of client relationships into lasting equity. This practical CLE shows attorneys how to ...
2026 was a very important year when it comes to federal procurement developments, Artificial Intelli...
Join us for this presentation to learn about the U.S. Court of Appeals for the Federal Circuit litig...
During this course you will learn about the Federal Firearm Rights Restoration program and the Feder...
As the legal landscape evolves, understanding both the recurring and emerging risks and challenges t...
I was wrongfully separated from the military and I will get no military pay and disability retiremen...
AI tools and workplace silence create the same problem for legal teams: the safeguards in place, inc...
Class action litigation continues to expand in both number of filings and monetary exposure, with se...